Dickon Hayne discusses the safety of sub-urothelial injection of durvalumab and examine the impact on tissue and circulating immune cell populations.
Image courtesy of interviewee. May 29, 2024
Search from 8000+ researchers, policymakers and practitioners across the subject spectrum
View more figures from University of Western Australia
View the page of Dickon Hayne
Read the Study
·Dickon Hayne discusses the safety of sub-urothelial injection of durvalumab and examine the impact on tissue and circulating immune cell populations.
Image courtesy of interviewee. May 29, 2024